---
title: "TPST Q1'26 Earnings: revenue estimate is 0 USD"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284752602.md"
description: "TPST (Tempest Therapeutics, Inc.) will announce its Q1'26 earnings on May 07 at 8:00 AM ET. The revenue estimate for Q1'26 is 0 USD, with an anticipated EPS of (0.28) USD. Previous EPS estimates showed a surprise increase in the last quarters. Revenue and EPS values are in USD, with reference data from FactSet."
datetime: "2026-04-30T11:00:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284752602.md)
  - [en](https://longbridge.com/en/news/284752602.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284752602.md)
---

# TPST Q1'26 Earnings: revenue estimate is 0 USD

TPST (Tempest Therapeutics, Inc.) is set to announce its Q1'26 results on May 07, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).

For Q1'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (0.28) USD. Learn more details at .

**Revenue & EPS values are provided in USD**

Q1'25

Q2'25

Q3'25

Q4'25

Q1'26

**Revenue Reported**

—

—

—

—

—

**Revenue Estimate**

—

—

—

—

—

**Revenue Surprise**

**EPS Reported**

(3.16)

(2.07)

(0.79)

(0.31)

**EPS Estimate**

(3.29)

(3.23)

(3.27)

(0.62)

(0.28)

**EPS Surprise**

+4.05%

+35.91%

+75.84%

+50.00%

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.

### Related Stocks

- [TPST.US](https://longbridge.com/en/quote/TPST.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Cardiff Oncology updates Phase 2 onvansertib data in first-line RAS-mutated mCRC trial](https://longbridge.com/en/news/287272648.md)
- [Tempest Therapeutics Q1 net loss widens on asset acquisition costs](https://longbridge.com/en/news/286464103.md)
- [Neurothera Labs Announces Adoption of Semi-Annual Reporting](https://longbridge.com/en/news/287119698.md)
- [Nuvalent to present pivotal ALKOVE-1 neladalkib data in ALK-positive NSCLC at ASCO 2026](https://longbridge.com/en/news/287275055.md)
- [Black Diamond reports Phase 2 silevertinib mPFS 15.2 months in frontline EGFR-mutant NSCLC](https://longbridge.com/en/news/287274011.md)